These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5705489)

  • 21. Viral hepatitis and the Australia antigen.
    Borst-Eilers E
    Folia Med Neerl; 1970; 13(5):166-70. PubMed ID: 4923492
    [No Abstract]   [Full Text] [Related]  

  • 22. [Liver bioptic findings in blood donors with increased serum transaminase activity].
    Goesch P; Maass M; Schwager A; Müller S
    Z Gesamte Inn Med; 1971 Apr; 26(8):257-61. PubMed ID: 5565820
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention of transmission of hepatitis B, hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testing.
    Busch MP
    Vox Sang; 1998; 74 Suppl 2():147-54. PubMed ID: 9704438
    [No Abstract]   [Full Text] [Related]  

  • 24. [The hepatitis epidemic in Godthåb in 1971-1972].
    Grove O; Larsen FB
    Ugeskr Laeger; 1974 Jan; 136(2):105-10. PubMed ID: 4130669
    [No Abstract]   [Full Text] [Related]  

  • 25. Detection of hepatitis carriers by serum glutamic oxalacetic transaminase activity.
    BANG NU; RUEGSEGGER P; LEY AB; LADUE JS
    J Am Med Assoc; 1959 Dec; 171():2303-6. PubMed ID: 13796422
    [No Abstract]   [Full Text] [Related]  

  • 26. Post-transfusion hepatitis in recipients of blood screened by newer assays.
    Koretz RL; Klahs DR; Ritman S; Damus KH; Gitnick GL
    Lancet; 1973 Sep; 2(7831):694-6. PubMed ID: 4125789
    [No Abstract]   [Full Text] [Related]  

  • 27. [Decrease in the occurrence of transfusion hepatitis in Göttingen hospitals following the introduction of routine transaminase and Australia antigen determination in blood donors].
    Arndt HJ; Frese R; Nachtwey K; Loos W; Kaboth U; Creutzfeldt W
    Verh Dtsch Ges Inn Med; 1971; 77():1193-5. PubMed ID: 5155989
    [No Abstract]   [Full Text] [Related]  

  • 28. [Incidence of hepatitis in Australia-antigen-positive blood donors (author's transl)].
    Eisenburg J; Meister P; Frühauf S; Greis I; Krumpoch B; Weinzierl M; Grunst J; Munte A; Rasch L
    Klin Wochenschr; 1973 Dec; 51(23):1143-50. PubMed ID: 4776562
    [No Abstract]   [Full Text] [Related]  

  • 29. [Proceedings: Prophylaxis of post-transfusion hepatitis (author's transl)].
    Deicher H
    Thoraxchir Vask Chir; 1973 Oct; 21(5):363-9. PubMed ID: 4131107
    [No Abstract]   [Full Text] [Related]  

  • 30. The significance of Australia-antibody in blood donors. Study of liver histology in donors and post-transfusion hepatitis in recipients.
    Reinicke V; Poulsen H; Banke O; Dybkjaer E
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Dec; 81(6):753-6. PubMed ID: 4205739
    [No Abstract]   [Full Text] [Related]  

  • 31. Hemophilia, hepatitis and HAA.
    Lewis JH
    Vox Sang; 1970; 19(3):406-9. PubMed ID: 5502767
    [No Abstract]   [Full Text] [Related]  

  • 32. [Determination of the transaminase index in the blood serum of blood donors].
    Czaplicki J; Szczepański J
    Pediatr Pol; 1965 Oct; 40(10):1075-8. PubMed ID: 5857994
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus.
    Prince AM; Brotman B; Grady GF; Kuhns WJ; Hazzi C; Levine RW; Millian SJ
    Lancet; 1974 Aug; 2(7875):241-6. PubMed ID: 4136143
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of Hepa-Gent and hepatitis associated antigen as determinants of liver disease.
    Hantman DI; Raymond J; Ritman SG; Gitnick GL
    Am J Med Technol; 1973 Mar; 39(3):90-3. PubMed ID: 4633789
    [No Abstract]   [Full Text] [Related]  

  • 35. [VALUE OF TRANSAMINASE DETERMINATION IN DONOR BLOOD IN THE PREVENTION OF HEPATITIS THROUGH TRANSFUSION].
    BRANDT KH; MEULENDIJK PN; POULIE NJ; SCHALM L; SCHULTE MJ; ZANEN HC
    Ned Tijdschr Geneeskd; 1963 Dec; 107():2312-9. PubMed ID: 14102353
    [No Abstract]   [Full Text] [Related]  

  • 36. [Role of donors in the spread of viral hepatitis].
    Grinshtein EA; Aleinik MD; Altman RSh; Klimova NIa; Piskunova AV
    Sov Med; 1973 Mar; 36(3):129-32. PubMed ID: 4756447
    [No Abstract]   [Full Text] [Related]  

  • 37. [Lysozyme and transaminase levels in the course of viral hepatitis].
    Moreno A; Pagliano Sassi L
    Epatologia; 1966; 12(2):288-91. PubMed ID: 5988890
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prevention of viral hepatitis in the blood transfusion services of the USSR and Czechoslovakia. Significance of screening tests for hepatitis B antigens and transaminases].
    Golosová TV; Burlev VA; Margolina AN; Horejsí J; Novák J; Kselíková M; Urbánková J
    Cas Lek Cesk; 1978 Oct; 117(40):1241-3. PubMed ID: 719671
    [No Abstract]   [Full Text] [Related]  

  • 39. [Technics of detection of Australia antigen and corresponding antibodies in blood transfusion centers].
    Vranckx R
    Arch Belg Med Soc; 1973 Apr; 31(4):222-54. PubMed ID: 4202183
    [No Abstract]   [Full Text] [Related]  

  • 40. Comments on the role of epidemiology in the investigation of hepatitis B virus.
    London WT; Blumberg BS
    Epidemiol Rev; 1985; 7():59-79. PubMed ID: 2996918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.